{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:05:43Z","timestamp":1784531143053,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002958","name":"Tabriz University of Medical Sciences Drug Applied Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119698","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T20:10:57Z","timestamp":1782331857000},"page":"119698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Repurposing of cyclophosphamide as a chemo\u2011immunotherapy agent in glioma using D8\/RI\u2011VAP modified-chitosan nanoparticles"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5681-5300","authenticated-orcid":false,"given":"Fatemeh","family":"Salahpour-Anarjan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solmaz Tabibi","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharareh","family":"Khavandkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roghaieh","family":"Khakpay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Rahbarghazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0186-3516","authenticated-orcid":false,"given":"Amir","family":"Zarebkohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2026.119698_bib1","article-title":"Identification of novel molecular and clinical biomarkers of survival in glioblastoma multiforme patients: a study based on the cancer genome atlas data","author":"Esteves","year":"2024","journal-title":"BioMed. Res. Int. 2024"},{"issue":"1","key":"10.1016\/j.biopha.2026.119698_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.11622\/smedj.2016044","article-title":"Glioblastoma multiforme outcomes of 107 patients treated in two Singapore institutions","volume":"58","author":"Cheo","year":"2017","journal-title":"Singap. Med. J."},{"issue":"12","key":"10.1016\/j.biopha.2026.119698_bib3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cancergen.2012.10.009","article-title":"Genetics of adult glioma","volume":"205","author":"Goodenberger","year":"2012","journal-title":"Cancer Genet."},{"key":"10.1016\/j.biopha.2026.119698_bib4","article-title":"Enhancing cancer immunotherapy: nanotechnology-mediated immunotherapy overcoming immunosuppression","author":"Chen","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2026.119698_bib5","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jconrel.2020.10.055","article-title":"Cell surface GRP78: an emerging imaging marker and therapeutic target for cancer","volume":"328","author":"Farshbaf","year":"2020","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biopha.2026.119698_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","article-title":"Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. & Oncol."},{"key":"10.1016\/j.biopha.2026.119698_bib7","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fbioe.2024.1403511","article-title":"Progress of nanoparticle drug delivery system for the treatment of glioma","volume":"12","author":"Lai","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"112","key":"10.1016\/j.biopha.2026.119698_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ads0449","article-title":"The immunology of brain tumors","volume":"10","author":"Bunse","year":"2025","journal-title":"Sci. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119698_bib9","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.3390\/cancers12092637","article-title":"Immunogenic cell death and elimination of immunosuppressive cells: a double-edged sword of chemotherapy","volume":"12","author":"Fumet","year":"2020","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.biopha.2026.119698_bib10","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119698_bib11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.tips.2011.08.005","article-title":"Cytochrome P450 enzymes in the brain: emerging evidence of biological significance","volume":"32","author":"Ferguson","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119698_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/jox15020044","article-title":"Brain Cytochrome P450: navigating neurological health and metabolic regulation","volume":"15","author":"Durairaj","year":"2025","journal-title":"J. Xenobiot."},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119698_bib13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0006-8993(97)01346-2","article-title":"Expression, induction and regulation of the cytochrome P450 monooxygenase system in the rat glioma C6 cell line","volume":"784","author":"Geng","year":"1998","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.biopha.2026.119698_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/ddc4040048","article-title":"Cyclophosphamide: old drug with great future","volume":"4","author":"Voelcker","year":"2025","journal-title":"Drugs Drug. Candidates"},{"issue":"1","key":"10.1016\/j.biopha.2026.119698_bib15","first-page":"612","article-title":"CNS Penetration of Cyclophosphamide and Metabolites in Mice Bearing Group 3 Medulloblastoma and Non-Tumor Bearing Mice","volume":"22","author":"Campagne","year":"2019","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119698_bib16","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","article-title":"Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents","volume":"28","author":"Galluzzi","year":"2015","journal-title":"Cancer Cell."},{"key":"10.1016\/j.biopha.2026.119698_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jconrel.2022.03.019","article-title":"Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers","volume":"345","author":"Farshbaf","year":"2022","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.biopha.2026.119698_bib18","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/anie.201411226","article-title":"A D-peptide ligand of nicotine acetylcholine receptors for brain-targeted drug delivery","volume":"54","author":"Wei","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.biopha.2026.119698_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.880377","article-title":"The potential of chitosan in nanomedicine: an overview of the cytotoxicity of chitosan based nanoparticles","volume":"13","author":"Frigaard","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119698_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122815","article-title":"CDX-modified chitosan nanoparticles remarkably reduce therapeutic dose of fingolimod in the EAE model of mice","volume":"636","author":"Sepasi","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119698_bib21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.actbio.2018.01.043","article-title":"Control of thiol-maleimide reaction kinetics in PEG hydrogel networks","volume":"70","author":"Jansen","year":"2018","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.biopha.2026.119698_bib22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/abio.1993.1263","article-title":"Quantitative Determination of Chitosan and the Percentage of Free Amino Groups","volume":"211","author":"Curotto","year":"1993","journal-title":"Anal. Biochem."},{"issue":"12","key":"10.1016\/j.biopha.2026.119698_bib23","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1021\/acs.molpharmaceut.1c00525","article-title":"Unraveling the effect of breast cancer patients\u2019 plasma on the targeting ability of folic acid-modified chitosan nanoparticles","volume":"18","author":"Nemati","year":"2021","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2026.119698_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.34172\/apb.2024.033","article-title":"Discovery of a novel dual targeting peptide for human glioma: from in silico simulation to acting as targeting ligand","volume":"14","author":"Sedghi Aminabad","year":"2024","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.biopha.2026.119698_bib25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: the MTT assay","volume":"731","author":"van Meerloo","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119698_bib26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10570-007-9122-3","article-title":"PEGylation of chitosan for improved solubility and fiber formation via electrospinning","volume":"14","author":"Du","year":"2007","journal-title":"Cellulose"},{"key":"10.1016\/j.biopha.2026.119698_bib27","first-page":"18","article-title":"Characterization of a dialdehyde chitosan generated by periodate oxidation","volume":"16","author":"Charhouf","year":"2014","journal-title":"biosensors"},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119698_bib28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijpharm.2012.04.004","article-title":"Chitosan-g-PEG nanoparticles ionically crosslinked with poly(glutamic acid) and tripolyphosphate as protein delivery systems","volume":"430","author":"Papadimitriou","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119698_bib29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijbiomac.2016.03.020","article-title":"Design, synthesis, and evaluation of chitosan conjugated GGRGDSK peptides as a cancer cell-targeting molecular transporter","volume":"87","author":"El-Sayed","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119698_bib30","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.biomaterials.2012.10.013","article-title":"Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases","volume":"34","author":"Malhotra","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2026.119698_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.carbpol.2018.03.030","article-title":"Dissociation of chitosan\/tripolyphosphate complexes into separate components upon pH elevation","volume":"192","author":"Mazancov\u00e1","year":"2018","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.biopha.2026.119698_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/acs.biomac.0c00663","article-title":"Thiolated chitosans: a multi-talented class of polymers for various applications","volume":"22","author":"Federer","year":"2021","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.biopha.2026.119698_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1049\/iet-nbt.2016.0055","article-title":"Synthesis and characterisation of PEG modified chitosan nanocapsules loaded with thymoquinone","volume":"11","author":"Vignesh Kumar","year":"2017","journal-title":"IET Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119698_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jconrel.2005.12.015","article-title":"Chitosan-PEG nanocapsules as new carriers for oral peptide delivery","volume":"111","author":"Prego","year":"2006","journal-title":"Eff. chitosan pegylation Degree J. Control. Release"},{"issue":"3","key":"10.1016\/j.biopha.2026.119698_bib35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/1568009043333014","article-title":"The role of cytochrome P450 in cytotoxic bioactivation: future therapeutic directions","volume":"4","author":"Rooney","year":"2004","journal-title":"Curr. Cancer Drug. Targets"},{"issue":"5","key":"10.1016\/j.biopha.2026.119698_bib36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/jnen\/nlac021","article-title":"Rat and mouse brain tumor models for experimental neuro-oncology research","volume":"81","author":"Sahu","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119698_bib37","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7439.1000395","article-title":"Targeting glioma with a dual mode optical and paramagnetic nanoprobe across the blood-brain tumor barrier","volume":"7","author":"Karki","year":"2016","journal-title":"J. Nanomed. Nanotechnol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119698_bib38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/1947-2714.100998","article-title":"Western blot: technique, theory, and trouble shooting","volume":"4","author":"Mahmood","year":"2012","journal-title":"N. Am. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119698_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103079","article-title":"Protocol to quantify immune cell distribution from the vasculature to the glioma microenvironment on sequential immunofluorescence multiplex images","volume":"5","author":"Najem","year":"2024","journal-title":"STAR Protoc."},{"issue":"24","key":"10.1016\/j.biopha.2026.119698_bib40","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1002\/anie.201100875","article-title":"Micelle-Based Brain-Targeted Drug Delivery Enabled by a Nicotine Acetylcholine Receptor Ligand","volume":"50","author":"Zhan","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.biopha.2026.119698_bib41","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1038\/s41467-018-05384-1","article-title":"Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption","volume":"9","author":"Guan","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119698_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and zeta potential \u2013 What they are and what they are not?","volume":"235","author":"Bhattacharjee","year":"2016","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.biopha.2026.119698_bib43","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nmat2442","article-title":"Understanding biophysicochemical interactions at the nano\u2013bio interface","volume":"8","author":"Nel","year":"2009","journal-title":"Nat. Mater."},{"issue":"4","key":"10.1016\/j.biopha.2026.119698_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","article-title":"Dynamic light scattering: a practical guide and applications in biomedical sciences","volume":"8","author":"Stetefeld","year":"2016","journal-title":"Biophys. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2026.119698_bib45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.15386\/mpr-1756","article-title":"A review of the current understanding of nanoparticles protein corona composition","volume":"93","author":"Breznica","year":"2020","journal-title":"Med. Pharm. Rep."},{"key":"10.1016\/j.biopha.2026.119698_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121458","article-title":"The impact of protein corona on the biological behavior of targeting nanomedicines","volume":"614","author":"Farshbaf","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119698_bib47","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.2147\/IJN.S129300","article-title":"Protein corona: a new approach for nanomedicine design","author":"Nguyen","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"10","key":"10.1016\/j.biopha.2026.119698_bib48","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.bbamem.2009.06.022","article-title":"Nanoparticles evading the reticuloendothelial system: role of the supported bilayer","volume":"1788","author":"Li","year":"2009","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Biomembr."},{"issue":"14","key":"10.1016\/j.biopha.2026.119698_bib49","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119698_bib50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens III","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2026.119698_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"issue":"12","key":"10.1016\/j.biopha.2026.119698_bib52","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/s41563-020-0755-z","article-title":"The dose threshold for nanoparticle tumour delivery","volume":"19","author":"Ouyang","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biopha.2026.119698_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.addr.2016.01.007","article-title":"Impact of particle elasticity on particle-based drug delivery systems","volume":"108","author":"Anselmo","year":"2017","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119698_bib54","article-title":"Nanoparticle-induced complement activation: implications for cancer nanomedicine","volume":"11","author":"La-Beck","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119698_bib55","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/cbe.4c00105","article-title":"Protein corona of nanoparticles: isolation and analysis","volume":"1","author":"Sun","year":"2024","journal-title":"Chem. Bio Eng."},{"issue":"2","key":"10.1016\/j.biopha.2026.119698_bib56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jconrel.2011.10.006","article-title":"Modeling of diffusion controlled drug delivery","volume":"161","author":"Siepmann","year":"2012","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.biopha.2026.119698_bib57","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","article-title":"Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release","volume":"116","author":"Kamaly","year":"2016","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119698_bib58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jconrel.2004.08.010","article-title":"Recent advances on chitosan-based micro- and nanoparticles in drug delivery","volume":"100","author":"Agnihotri","year":"2004","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.biopha.2026.119698_bib59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0378-4274(84)90156-5","article-title":"Cytotoxicity of cyclophosphamide and acrylamide in glioma and neuroblastoma cell lines cocultured with liver cells","volume":"20","author":"Ericsson","year":"1984","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2026.119698_bib60","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2019.11.025","article-title":"Medium dose intermittent cyclophosphamide induces immunogenic cell death and cancer cell autonomous type I interferon production in glioma models","volume":"470","author":"Du","year":"2020","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.biopha.2026.119698_bib61","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s12088-020-00896-1","article-title":"Vitro Cytotoxicity Study of Cyclophosphamide, Etoposide and Paclitaxel on Monocyte Macrophage Cell Line Raw 264.7","volume":"60","author":"Yadav","year":"2020","journal-title":"Indian. J. Microbiol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119698_bib62","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10517-005-0358-3","article-title":"Possible role of P-glycoprotein in cyclophosphamide resistance of transplanted mouse RLS lymphosarcoma","volume":"139","author":"Grishanova","year":"2005","journal-title":"Bull. Exp. Biol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2026.119698_bib63","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","article-title":"Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense","volume":"204","author":"Leslie","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"19","key":"10.1016\/j.biopha.2026.119698_bib64","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.3390\/polym13193210","article-title":"Fabrication and Characterization of Paclitaxel and Resveratrol Loaded Soluplus Polymeric Nanoparticles for Improved BBB Penetration for Glioma Management","volume":"13","author":"Hussain","year":"2021","journal-title":"Polymers"},{"issue":"3","key":"10.1016\/j.biopha.2026.119698_bib65","first-page":"629","article-title":"Toxicity of Cisplatin-Loaded Poly Butyl Cyanoacrylate Nanoparticles in a Brain Cancer Cell Line: anionic Polymerization Results","volume":"18","author":"Mohamadi","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"36","key":"10.1016\/j.biopha.2026.119698_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202503820","article-title":"The challenges and opportunities of protein coronas for nanoscale biomolecular sensing","volume":"21","author":"Cheeseman","year":"2025","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.biopha.2026.119698_bib67","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2026.119698_bib68","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/cancers17050821","article-title":"Current landscape and future directions in cancer immunotherapy: therapies, trials, and challenges","volume":"17","author":"Bandara","year":"2025","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.biopha.2026.119698_bib69","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.biopha.2026.119698_bib70","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","article-title":"Smart cancer nanomedicine","volume":"14","author":"van der Meel","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"15","key":"10.1016\/j.biopha.2026.119698_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158044","article-title":"Review of dendritic cells, their role in clinical immunology, and distribution in various animal species","volume":"22","author":"Zanna","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2026.119698_bib72","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell. Death Dis."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:38:06Z","timestamp":1784529486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226007341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":72,"alternative-id":["S0753332226007341"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119698","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing of cyclophosphamide as a chemo\u2011immunotherapy agent in glioma using D8\/RI\u2011VAP modified-chitosan nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119698"}}